Results 31 to 40 of about 2,460 (186)
Background/AimsAs the incidence rate of and mortality from pseudomembranous colitis (PMC) are increasing worldwide, it is important to study the simple predictive risk factors for PMC among patients with hospital-acquired diarrhea (HAD).
doaj +1 more source
Microbiota–Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases
Bacterial dysbiosis results from microbiota imbalances, diet, lifestyle, and other factors that lead to conditions such as IBS, IBD, acne, dermatitis, and dental diseases. The current therapeutic approaches include probiotics, prebiotics, synbiotics, microbiota transplantation, and phage therapy.
Siau Wui Chin +3 more
wiley +1 more source
Initially, 166 subjects aged 65 years or older with severe LRTIs met the diagnostic criteria, but 30 cases were excluded due to incomplete clinical data, and 17 cases were excluded due to the presence of malignancies, connective tissue diseases, or long‐term use of immunosuppressive agents. Ultimately, 119 patients were included in the study. The study
Tianqi Qi +8 more
wiley +1 more source
Identification of locally isolated clostridium difficile from rabbits [PDF]
Clostridium difficile is one of the most important pathogens causing diarrhea and enteritis in rabbits as it causes pseudomembranous colitis that leads to intestinal damage and deaths. In this study, screening of rabbit farms from different localities in
Abdella, Y. A. +5 more
core +1 more source
A Report of a patient with Diarrhea: Pseudomembranous Colitis
Background and Objectives: Pseudomembranous colitis is an advanced form of infection with clostridium difficile, which damage epithelial cells following colonization in the intestine and production of toxins A and B.
Ahmad Hormati +5 more
doaj
Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases
The abstract depicts the gut‐brain axis, illustrating the bidirectional communication between the gastrointestinal tract and the central nervous system. Probiotics can induce the production of neurotrophins, neurotransmitters, SCFAs, and contribute to increased antioxidant levels, which can benefit brain health. In contrast, antibiotics can disrupt the
Tobiloba S. Olajide +1 more
wiley +1 more source
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
This article reviews the use of fecal microbiota transplantation (FMT) to treat intestinal diseases like recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). It discusses FMT's efficacy, influencing factors such as donor selection, recipient characteristics, and treatment protocols ...
Shuna Hou +4 more
wiley +1 more source
Role of microbiota in pain: From bench to bedside
Pain is closely linked to microbes. The microbiota modulates pain perception through three mechanisms: microbiota‐derived metabolites, immunoregulation, and direct stimulation on neurons. Therapeutic strategies like probiotics, fecal microbiota transplantation, and dietary changes show significant potential in pain management.
Huiguang Ren +5 more
wiley +1 more source
The safety of vonoprazan was evaluated in an integrated analysis of data from clinical trials and post‐marketing experience in adults with symptomatic gastro‐oesophageal reflux disease or erosive oesophagitis. Vonoprazan was well tolerated, with a similar safety profile to proton pump inhibitor comparators.
Colin W. Howden +8 more
wiley +1 more source
Multiple roles of gut microbiota in tumor immunotherapy. Gut microbiota plays a crucial role in programming innate and acquired immune responses, often affecting immunotherapy efficacy. They serve as biomarkers of efficacy and prognosis, and provide insights into microbiota‐based therapeutic strategies.
Binyan Zhao +5 more
wiley +1 more source

